CD14 and acute coronary syndrome: Intermediate monocytes (CD14<sup>++</sup>CD16<sup>+</sup>), a highly pro-inflammatory subset, are linked to endothelial activation, thrombus formation, and poor outcomes in acute coronary syndrome (ACS), suggesting a role in the transition to plaque vulnerability.